Menu Close Menu

Menu

KOJIC ACID

Score:

Data: Limited

  • Other Concerns
  • Functions
  • About the Chemical
  • Synonyms
  • Use restrictions (high) and Endocrine disruption (moderate)

Cancer

Cancer concern is LOW_MODERATE

Developmental & Reproductive Toxicity

Developmental & reproductive toxicity concern is LOW

Allergies & Immunotoxicity

Allergies & immunotoxicity concern is MODERATE

Products with this Ingredient

Expand content Collapse content
mask2 products
toners/astringents1 products
serums & essences1 products
exfoliant/scrub1 products
bar soap1 products
facial cleanser1 products
facial moisturizer/treatment1 products

Allergies/immunotoxicity

Expand content Collapse content
Concern Reference
Possible human Sensitizer toxicant or allergenScientific Committee on Consumer Safety (SCCS) 2012. DRAFT OPINION ON Kojic Acid, June 2012. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_098.pdf

Use restrictions

Expand content Collapse content
Concern Reference
Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - unsafe for use on injured or damaged skinScientific Committee on Consumer Safety (SCCS) 2012. DRAFT OPINION ON Kojic Acid, June 2012. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_098.pdf
Recommended restricted in cosmetics - use, concentration, or manufacturing restrictions - anyScientific Committee on Consumer Safety (SCCS) 2012. DRAFT OPINION ON Kojic Acid, June 2012. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_098.pdf
Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualificationsCosmetic Ingredient Review Assessments
Determined safe for use in cosmetics, subject to concentration or use limitations - anyBurnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Andersen FA Final report of the safety assessment of Kojic acid as used in cosmetics. Int J Toxicol. 2010 Nov-Dec;29(6 Suppl):244S-73. Review.

Cancer

Expand content Collapse content
Concern Reference
Limited evidence of carcinogenicityScientific Committee on Consumer Products SCCP OPINION ON Kojic acid The SCCP adopted this opinion at its 17 th plenary of 30 September 2008
Limited or incomplete evidence of cancer according to safety/hazard data – government assessment cannot classify as human carcinogen due to data gapsWorld Health Organization, International Agency for Research on Cancer IARC Monographs Programme on the Evaluation of Carcinogenic Risks to Humans. Lists of Group 1, 2a, and 2b substances can be obtained. http://monographs.iarc.fr/ENG/Classification/index.php; Vol 79;2001

Endocrine disruption

Expand content Collapse content
Concern Reference
Limited evidence of endocrine disruptionScientific Committee on Consumer Products SCCP OPINION ON Kojic acid The SCCP adopted this opinion at its 17 th plenary of 30 September 2008

Data gaps

Expand content Collapse content
Concern Reference
Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in productCosmetic Ingredient Review Assessments
481 studies in PubMed science library may include information on the toxicity of this chemicalNLM PubMed

Data Sources

  • Scientific Committee on Consumer Safety (SCCS) 2012. DRAFT OPINION ON Kojic Acid, June 2012. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_098.pdf
  • CIR (Cosmetic Ingredient Review). 2006. CIR Compendium, containing abstracts, discussions, and conclusions of CIR cosmetic ingredient safety assessments. Washington DC.
  • Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Andersen FA Final report of the safety assessment of Kojic acid as used in cosmetics. Int J Toxicol. 2010 Nov-Dec;29(6 Suppl):244S-73. Review.
  • Scientific Committee on Consumer Products SCCP OPINION ON Kojic acid The SCCP adopted this opinion at its 17 th plenary of 30 September 2008
  • World Health Organization, International Agency for Research on Cancer IARC Monographs Programme on the Evaluation of Carcinogenic Risks to Humans. Lists of Group 1, 2a, and 2b substances can be obtained. http://monographs.iarc.fr/ENG/Classification/index.php; Vol 79;2001
  • NLM (National Library of Medicine). 2012. PubMed online scientific bibliography data. http://www.pubmed.gov.

About this Ingredient's Score Range

  • This ingredient’s score is higher if used in products intended for damaged skin due to increased risk of absorption.
  • Products with the EWG VERIFIED mark have met use restrictions and warnings based on EWG review of company data.

ABOUT THE SKIN DEEP® RATINGS

EWG provides information on personal care product ingredients from the published scientific literature, to supplement incomplete data available from companies and the government. The ratings below indicate the relative level of concern posed by exposure to the ingredients in this product - not the product itself - compared to other product formulations. The ratings reflect potential health hazards but do not account for the level of exposure or individual susceptibility, factors which determine actual health risks, if any. Learn more | Legal Disclaimer

ABOUT EWG VERIFIED™

Beyond providing Skin Deep® as an educational tool for consumers, EWG offers its EWG VERIFIED™ mark as a quick and easily identifiable way of conveying personal care products that meet EWG's strict health criteria. Before a company can use EWG VERIFIED™ on such products, the company must show that it fully discloses the products' ingredients on their labels or packaging, they do not contain EWG ingredients of concern, and are made with good manufacturing practices, among other criteria. Note that EWG receives licensing fees from all EWG VERIFIED™ member companies that help to support the important work we do. Learn more | Legal Disclaimer